TEVIMBRA 100MG INJECTION

Form: Injection

Pack Size: 1 VIAL

Marketed by: GLENMARK PHARMACEUTICALS LTD (ONCOLOGY DIV)

MRP: ₹59584.28

GLENMARK PHARMACEUTICALS LTD (ONCOLOGY DIV): Tevimbra 100MG Injection, 1 vial, salt tislelizumab 100mg. Its MRP stays at Rs 59,584.28 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 45,397.55. Group: PD-1 inhibitor (immunotherapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: IV infusion in hospital only; store at 2-8 C, do not freeze. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.